- •We prove the safety and feasibility of a two-treatment approach with SCE therapy.
- •The percentage of naïve CD4+ and TCM cells were increased, but the percentage of CD4+ TEM and CD8+ TEMcells were declined.
- •The expression of CCR7 on naïve T and TCM cells were markedly increased.
The current studies demonstrated the safety and feasibility of a two-treatment approach with Stem Cell Educator therapy and well tolerated in all subjects, without significantly changing the numbers and ratios of different cell compartments in the subjects' immune system. Both the percentage of CD4+ and CD8+ effector memory T cells were substantially decreased in the peripheral blood of T1D subjects, whereas the percentage of CD4+ central memory T cells was markedly and constantly increased. These findings provide a solution to alter the autoimmune memory compartment in T1D, while mitigating safety and ethical concerns associated with conventional immune therapies.